VCYT

36.71

2.14% 0.77

Handel nachbörslich: 36.71

Veracyte Inc (VCYT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$35.94

Offen:

$36.05

24-Stunden-Volumen:

792.96K

Relative Volume:

1.05

Marktkapitalisierung:

$1.74B

Einnahmen:

$399.58M

Nettoeinkommen (Verlust:

$-54.04M

KGV:

-91.77

EPS:

-0.4

Netto-Cashflow:

$40.13M

1W Leistung:

-5.61%

1M Leistung:

+6.59%

6M Leistung:

+60.45%

1J Leistung:

+45.39%

1-Tages-Spanne:

$35.73

$37.30

1-Wochen-Bereich:

$35.37

$39.98

52-Wochen-Spanne:

$18.61

$41.43

Veracyte Inc Stock (VCYT) Company Profile

Firmenname

Veracyte Inc

Sektor

Healthcare (1196)

Branche

Diagnostics & Research (56)

Telefon

(650) 243-6300

Adresse

6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Mitarbeiter

Twitter

@veracyte

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

VCYT's Discussions on Twitter

Vergleichen Sie VCYT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VCYT	36.71	1.74B	399.58M	-54.04M	40.13M	-0.40
TMO	501.29	192.46B	42.37B	6.14B	7.78B	15.26
DHR	230.06	166.23B	23.74B	3.89B	4.98B	7.93
A	126.92	36.47B	6.50B	1.41B	1.42B	3.82
IQV	191.04	34.67B	15.32B	1.41B	1.96B	5.95
IDXX	419.83	34.38B	3.84B	866.24M	792.60M	9.80

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-01-18	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-01-07	Eingeleitet	Stephens	Overweight
2021-11-18	Fortgesetzt	Goldman	Buy
2021-06-15	Eingeleitet	Raymond James	Outperform
2021-02-18	Fortgesetzt	Needham	Buy
2021-01-28	Eingeleitet	Truist	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-09	Eingeleitet	Morgan Stanley	Underweight
2019-07-31	Eingeleitet	Lake Street	Buy
2019-07-02	Eingeleitet	Needham	Buy
2018-11-29	Herabstufung	Janney	Buy → Neutral
2018-10-31	Hochstufung	Janney	Neutral → Buy
2017-11-07	Herabstufung	Janney	Buy → Neutral
2017-11-07	Herabstufung	Piper Jaffray	Overweight → Neutral
2017-08-31	Fortgesetzt	BTIG Research	Buy
2016-11-14	Fortgesetzt	Leerink Partners	Outperform
2015-12-18	Eingeleitet	Cantor Fitzgerald	Buy
2015-06-11	Bestätigt	Leerink Partners	Outperform
2013-11-26	Eingeleitet	William Blair	Outperform

Alle ansehen

Veracyte Inc Aktie (VCYT) Neueste Nachrichten

10:51 AM

Veracyte (NASDAQ:VCYT) Given New $28.00 Price Target at Morgan Stanley - MarketBeat

10:51 AM

03:46 AM

Assetmark Inc. Has $93,000 Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

03:46 AM

Nov 16, 2024

State of New Jersey Common Pension Fund D Has $2.09 Million Stake in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Veracyte initiated with an Outperform at Wolfe on growth, margin potential - TipRanks

Nov 15, 2024

Insider Sale: CFO Rebecca Chambers Sells Shares of Veracyte Inc (VCYT) - GuruFocus.com

Nov 14, 2024

Veracyte CFO Rebecca Chambers sells $585,663 in company stock - Investing.com

Nov 14, 2024

Veracyte director Robert Epstein sells $574,830 in stock - Investing.com

Nov 14, 2024

Sumitomo Mitsui Trust Group Inc. Cuts Position in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 14, 2024

Nov 12, 2024

Artisan Partners Limited Partnership Bolsters Stake in Veracyte Inc - GuruFocus.com

Nov 12, 2024

Veracyte, Inc. (NASDAQ:VCYT) Is About To Turn The Corner - Simply Wall St

Nov 12, 2024

Nov 11, 2024

Peregrine Asset Advisers Inc. Makes New Investment in Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 11, 2024

Nov 10, 2024

Analysts Set Veracyte, Inc. (NASDAQ:VCYT) PT at $39.71 - MarketBeat

Nov 10, 2024

Nov 09, 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

Nov 09, 2024

Veracyte, Inc. (NASDAQ:VCYT) Shares Sold by AEGON ASSET MANAGEMENT UK Plc - MarketBeat

Nov 09, 2024

Nov 08, 2024

Wellington Management Group LLP's Strategic Reduction in Veracyte Inc Holdings - GuruFocus.com

Nov 08, 2024

Veracyte (VCYT) Tops Q3 Earnings and Revenue Estimates - MSN

Nov 08, 2024

Veracyte (NASDAQ:VCYT) Stock Price Expected to Rise, Scotiabank Analyst Says - MarketBeat

Nov 08, 2024

Veracyte price target raised to $44 from $40 at Scotiabank - TipRanks

Nov 08, 2024

Veracyte, Inc. (NASDAQ:VCYT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

ARK Investment Management LLC Sells 1,888,552 Shares of Veracyte, Inc. (NASDAQ:VCYT) - MarketBeat

Nov 08, 2024

Veracyte stock target lifted, sustains buy rating on strong Q3 results - Investing.com Australia

Nov 08, 2024

Veracyte Third Quarter 2024 Earnings: Beats Expectations - Yahoo Canada Finance

Nov 08, 2024